Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy.
D000814:Aniline Compounds / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001798:Blood Proteins / Q000032:analysis; D001835:Body Weight; D003622:Dapsone / Q000627:therapeutic use; D004893:Erythema Nodosum / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007097:Imines / Q000627:therapeutic use; D007918:Leprosy / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D009461:Neurologic Manifestations; D010619:Phenazines / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D012008:Recurrence
D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D001798:Blood Proteins; D007097:Imines; D010619:Phenazines; D003622:Dapsone; D011239:Prednisolone